AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

However, their value in the management of uncomplicated skin infections is not yet clearly defined. This literature review discusses various topical antibiotic treatment options for uncomplicated ...

There are a few options to treat a yeast infection based on symptoms and severity of the case. Different courses of treatment have slightly different timelines, but most medications are used for one ...

A new study from the University of Minnesota and Mayo Clinic has found that people who are hospitalized for infections face a ...

HIV prevention shot achieved a 96% success rate in clinical trials, but accessibility and regulatory hurdles remain a ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

This led them to the conclusion that antibiotics, antivirals and anti-inflammatory drugs were all associated with reduced ...

A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment. UTIs are one of the most prevalent bacterial infections ...

Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...